MISSD

10/09/2025

🚨 As countries mark World Mental Health Day tomorrow, we call on regulators to strengthen su***de warnings for medications that can cause su***de and psychiatric adverse effects.

France just became the first nation to add a clear su***de warning on finasteride—will the U.S. follow this lead?
🔗 Read our release:

Foundation Urges Health Regulators Worldwide to Strengthen Warnings and Transparency

10/07/2025

🌟 Today we're happy to share our annual highlights — full of progress, purpose, and hope!

From expanding akathisia education across new audiences to launching our big '50 in 5' campaign, 2025 has been a year of growth and impact.

If you’ve already supported MISSD, thank you for helping us prevent harm and save lives through education, awareness, and advocacy. 💙

If you haven’t, there’s still time to make a tax-deductible donation and help us reach even more people in 2026.

10/06/2025

France Adds Su***de Risk Warning to Finasteride But the US and other Nations Stay Silent

France’s national drug agency (ANSM) has issued a new safety alert for finasteride, a medication prescribed for hair loss and enlarged prostate. The updated label now warns of psychiatric side effects, including suicidal thoughts, which may persist even after stopping the drug. France has now required patient cards, updated leaflets, and letters to physicians to raise awareness.

Between 1985 and 2024, more than 100 psychiatric or sexual side-effect cases were reported in France—including one su***de and four su***de attempts.

People harmed by finasteride, including many who died by iatrogenic su***de, have been warning regulators for years. These tragedies are preventable. Citizens of every country deserve clear, life-saving warnings about finasteride’s psychiatric risks.

D'après l'Agence nationale pour la sécurité du médicament, les personnes qui prennent du finastéride 1mg doivent respecter certaines règles.

10/06/2025

Science Friday did a good job of highlighting the adverse effects of SSRI withdrawal, one of which is often withdrawal akathisia. Listen & learn.

Without robust long-term data, physicians and patients continue debating the severity and significance of SSRI withdrawal symptoms.

10/01/2025

🎙️"By relaunching Akathisia Stories, we honor those lost to akathisia and help prevent future tragedies," said Wendy Dolin, MISSD founder.

The new season is here. Don’t miss these powerful conversations that raise awareness and can save lives.
🎧 Listen now:

In this premiere of Akathisia Stories, host Ivan Kaiser sits down with his aunt, Kristina Kaiser, for a powerful conversation about medication safety, loss, ...

09/30/2025

We’re Baaaack! 🎙️
The Akathisia Stories podcast has returned with a new host and powerful episodes—sharing lived experiences, real truths, and vital education to save lives.

As Su***de Prevention Awareness Month ends, MISSD spotlights a family’s story of preventable loss

09/26/2025

SSRI withdrawal symptoms shouldn't be brushed aside as “nervousness” or signs of “relapse.” This is misleading—and it puts people at risk.

Even more troubling? Articles that leave out withdrawal akathisia,. Any article about antidepressant withdrawal that omits akathisia is incomplete. People deserve honesty, not euphemisms. Clear information helps patients, families, and providers make safer choices.
See: https://tinyurl.com/mrhxpta3

09/20/2025

It's International Akathisia Awareness Day and we're pleased to release our latest public health video today. It's a day of observance and awareness we created years ago to honor those lost to akathisia and help ensure accurate info to save lives..

Please see and share. Together, we're saving lives.💙

Today is International Akathisia Awareness Day. MISSD created IAAD years ago to help the public and prescribers better understand akathisia so that lives can...

09/11/2025

Yesterday was World Su***de Prevention Day—but most mental health and su***de prevention organizations stayed silent on the “A” word.

Akathisia silence is deafening—and deadly. This medication-induced disorder can cause self-harm, violence, and su***de. Awareness, accurate diagnosis, and honest drug trial reporting can prevent these deaths. Read more:

A Serious Medication-Induced Disorder Linked to Su***de Demands Clinician Training and Public Awareness

09/02/2025

💛 Life-saving awareness now on display in Chicago! Thanks to Wintrust Bank’s generous initiative, our digital billboard is reaching millions during Su***de Prevention Month.

Every view, share, and conversation can reduce avoidable harm and save lives.

08/28/2025

The truth is clear: GSK concealed Paxil risks and, like other pharma companies, promoted SSRIs off-label -- including to kids, despite no FDA approval.

Now a medical journal is considering a retraction of the 2001 "study" it published that falsely said Paxil was safe and effective for adolescents. The data were manipulated, and serious side effects—like suicidal thoughts—were buried.

We can’t change the past, but we can protect the future. Please share MISSD’s resources to help others recognize the warning signs of akathisia and prevent avoidable harm.

The full STAT article is subscription-only, but this knowledge is now (belatedly) well established.

Amid demand for retraction, a leading medical journal is reviewing a discredited study published in 2001 that touted the benefits of a depression pill for adolescents.

08/26/2025

New Podcast Episode: In this gripping conversation, MISSD founder Wendy Dolin discusses akathisia with Katinka Blackford Newman, founder of Antidepressant Risks.

Wendy opens up about her personal loss and why it's critical to know about akathisia prior to starting new medications or making any medication changes.

MISSD has spent more than a decade working to educate both the public and medical professionals about medication-induced suicidality and su***de. Help save lives—share, comment, and subscribe for more educational content.

Watch the full interview at

Antidepressant Risks shares stories of people who have been harmed by antidepressants and aims to raise awareness of potential antidepressant side effects and dangers.